Cargando…

Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review

SIMPLE SUMMARY: Approximately 30% of patients diagnosed with cancer will ultimately develop brain metastases. Many improvements have been made in systemic and local cancer treatments, which have increased overall survival but also, as a consequence, the number of patients who present with local recu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucia, François, Touati, Ruben, Crainic, Nicolae, Dissaux, Gurvan, Pradier, Olivier, Bourbonne, Vincent, Schick, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508410/ https://www.ncbi.nlm.nih.gov/pubmed/34638412 http://dx.doi.org/10.3390/cancers13194929

Ejemplares similares

Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence
por: Touati, Ruben, et al.
Publicado: (2023)

Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases
por: Guénolé, Morgan, et al.
Publicado: (2020)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy
por: Lucia, François, et al.
Publicado: (2020)

Toxicity in patients treated with permanent prostate brachytherapy using intraoperatively built custom-linked seeds versus loose seeds
por: Ollivier, Luc, et al.
Publicado: (2020)

Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy
por: Lucia, François, et al.
Publicado: (2022)

Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer
por: Lucia, François, et al.
Publicado: (2021)

A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy
por: Boussion, Nicolas, et al.
Publicado: (2021)

Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Narrative Review of the Post-Operative Management of Prostate Cancer Patients: Is It Really the End of Adjuvant Radiotherapy?
por: Bourbonne, Vincent, et al.
Publicado: (2022)

VMAT-Based Planning Allows Sparing of a Spatial Dose Pattern Associated with Radiation Pneumonitis in Patients Treated with Radiotherapy for a Locally Advanced Lung Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy
por: Moreau, Juliette, et al.
Publicado: (2018)

Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study
por: Dissaux, Brieg, et al.
Publicado: (2022)

Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Combination of Radiomics Features and Functional Radiosensitivity Enhances Prediction of Acute Pulmonary Toxicity in a Prospective Validation Cohort of Patients with a Locally Advanced Lung Cancer Treated with VMAT-Radiotherapy
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Stereotactic Radiation Therapy of Single Brain Metastases: A Literature Review of Dosimetric Studies
por: Chambrelant, Isabelle, et al.
Publicado: (2023)

Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma
por: Allard, Bastien, et al.
Publicado: (2022)

Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?
por: Bourbonne, Vincent, et al.
Publicado: (2023)

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2019)

A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-(68) Perfusion PET/CT
por: Lucia, François, et al.
Publicado: (2023)

External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Bordron, Anaïs, et al.
Publicado: (2022)

Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis
por: Tremblay, Guillaume, et al.
Publicado: (2023)

Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature
por: Londero, Francesco, et al.
Publicado: (2020)

Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Bourbonne, Vincent, et al.
Publicado: (2022)

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2020)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
por: Palmisciano, Paolo, et al.
Publicado: (2022)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer
por: Meng, Mao-Bin, et al.
Publicado: (2015)

Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives
por: Kinj, Rémy, et al.
Publicado: (2022)

Fractionated stereotactic radiation therapy for intact brain metastases
por: Marcrom, Samuel R., et al.
Publicado: (2017)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Prognostic value of (18)F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma
por: Dissaux, Gurvan, et al.
Publicado: (2020)

Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis
por: Barillaro, Angela, et al.
Publicado: (2023)

Frameless stereotactic body radiation therapy for multiple lung metastases
por: Li, Qilin, et al.
Publicado: (2014)

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
por: Mills, Matthew N., et al.
Publicado: (2021)

Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

RADI-25. REPEAT STEREOTACTIC RADIOSURGERY FOR RECURRENT BRAIN METASTASES
por: Krivosheya, Daria, et al.
Publicado: (2019)

The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Oligoprogressive Breast Cancer: A Systematic Review
por: Yan, Bernie, et al.
Publicado: (2023)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ep38a57rplp6cgptg7kitib57k